Some of pharma’s biggest players — including Merck, Amgen, Abbvie, and Gilead — formed an alliance to fight looming M&A reforms.
Our daily email brings you smart and engaging news and analysis on the biggest stories in business and finance. For free.
The weight loss drug market could be worth $100 billion in the next few years. Naturally, other companies want in.
On Friday, Beijing announced that a trade-in program that previously applied to big appliances and cars will now be widened to smartphones.
As the New Year rolls in, Wall Street is preparing for a slew of listing announcements from private equity-backed firms.
It’s understandable if you failed to notice one meaty if unglamorous trend on Wall Street: Private equity’s love affair with franchising.